Lamberts, Morten

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study

Lamberts, M., Olesen, J. B., Ruwald, M. H., Hansen, C. M., Karasoy, D., Kristensen, S. L., Køber, L., Torp-Pedersen, C., Gislason, G. H., & Hansen, M. L. (2012) · Circulation

Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases

Cited by 413

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the Working Group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

Schmidt, M., Lamberts, M., Olsen, A.-M. S., Fosbøll, E., Niessner, A., Tamargo, J., Rosano, G., Agewall, S., Kaski, J. C., Kjeldsen, K., et al. (2016) · European Heart Journal

Inflammatory mediators and NSAID effectsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 164

The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study

Ruwald, M. H., Hansen, M. L., Lamberts, M., Hansen, C. M., Hojgaard, M. V., Kober, L., Torp-Pedersen, C., Hansen, J., & Gislason, G. H. (2012) · Europace

Cardiovascular Syncope and Autonomic DisordersPharmaceutical Practices and Patient Outcomes

Cited by 118

Accuracy of the ICD-10 discharge diagnosis for syncope

Ruwald, M. H., Hansen, M. L., Lamberts, M., Kristensen, S. L., Wissenberg, M., Olsen, A.-M. S., Christensen, S. B., Vinther, M., Kober, L., Torp-Pedersen, C., et al. (2013) · Europace

Medical Coding and Health InformationCardiovascular Syncope and Autonomic Disorders

Cited by 79

Comparison of Incidence, Predictors, and the Impact of Co-Morbidity and Polypharmacy on the Risk of Recurrent Syncope in Patients <85 Versus ≥85 Years of Age

Ruwald, M. H., Hansen, M. L., Lamberts, M., Hansen, C. M., Numé, A.-K., Vinther, M., Køber, L., Torp-Pedersen, C., Hansen, J., & Gislason, G. H. (2013) · The American Journal of Cardiology

Cardiovascular Syncope and Autonomic DisordersPharmaceutical Practices and Patient Outcomes

Cited by 59

Sleep Apnea, the Risk of Developing Heart Failure, and Potential Benefits of Continuous Positive Airway Pressure (CPAP) Therapy

Holt, A., Bjerre, J., Zareini, B., Koch, H., Tønnesen, P., Gislason, G. H., Nielsen, O. W., Schou, M., & Lamberts, M. (2018) · Journal of the American Heart Association

Obstructive Sleep Apnea ResearchHeart Failure Treatment and Management

Cited by 54

Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study

Zareini, B., Rørth, R., Holt, A., Mogensen, U. M., Selmer, C., Gislason, G., Schou, M., Køber, L., Torp-Pedersen, C., Lamberts, M., et al. (2019) · Cardiovascular Diabetology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 49